Managing Acute Coronary Syndrome and Surgical Revascularization in a Patient With Severe Haemophilia A on Emicizumab: Lessons Learned From a Clinical Case

Haemophilia 2026

View at publisher
Authors: Paige Muir, Rohan Sanjanwala, Angelina Marinkovic, Krishnan Ramanathan, Shannon C. Jackson
DOI: 10.1111/hae.70210
Cited by: 0
References: 15

Abstract

Dr. Jackson has attended or chaired advisory board meetings for Pfizer, Novo-Nordisk, Sanofi, Octapharma, Bayer and Roche and has participated on the planning committee for Bayer and Roche. The data that support the findings of this study are available upon reasonable request from the corresponding author.

Fields of Study & Subjects

Hemophilia Treatment and Research Acute Myocardial Infarction Research Cardiac and Coronary Surgery Techniques

Publication details

Journal / source
Haemophilia
Volume
32
Issue
2
Pages
573–576
Publication date
18 January 2026
Language
EN